Revolutionising industries while unlocking immense potential for future innovation
Risk Disclosure
- INVESTMENT INVOLVES RISKS. The value of the Fund can be volatile and investors may not get back the amount originally invested. Past performance is not indicative of future results.
- Franklin Technology Fund
- Franklin Biotechnology Discovery Fund
- Franklin U.S. Opportunities Fund
Franklin Technology Fund
- Franklin Technology Fund invests principally in equity securities of technology companies of any size located anywhere in the world.
- The Fund is subject to market risk, equity risk, foreign currency risk, RMB Currency and Conversion risk, liquidity risk, biotechnology, communication and technology sectors risk, concentration risk, growth stocks risk, Chinese market risk, class hedging risk, counterparty risk, smaller and midsize companies risk, Private Investments in Public Equity risk, private companies risk, special purpose acquisition companies risk and derivative instruments risk.
- Security lending may involve the risk that the borrower may fail to return the securities lent out in a timely manner and the value of the collateral may fall below the value of the securities lent out, which may result in a substantial loss to the Fund.
- The Fund may at its discretion pay dividends out of the capital or out of gross income of the Fund while paying all or part of the Fund’s fees and expenses out of the capital of the Fund, which results in effectively paying dividends out of capital. Payment of dividends out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment. Any distributions involving payment of dividends out of the Fund’s capital or payment of dividends effectively out of the Fund’s capital (as the case may be) may result in an immediate reduction of the net asset value per share.
- “Plus” share classes that offer, under normal market conditions, dividend distribution at a pre-determined annual percentage of the net asset value per share that is not linked to income or capital gains, may either be paying out both income and capital in distribution payments, or not substantially distributing all the investment income which a share class has earned. Such share classes may continue to distribute in periods that the Fund has negative returns or is making losses, which further reduces the net asset values of such share classes. In extreme circumstances, investors may not be able to get back the original investment amount.
- Investors should not invest based on this marketing material alone. Offering documents should be read for further details, including the risk factors. Before you decide to invest, you should make sure the intermediary has explained to you that the Fund is suitable to you.
Franklin Biotechnology Discovery Fund
- Franklin Biotechnology Discovery Fund invests principally in equity securities issued by biotechnology companies in the U.S. and other countries.
- The Fund is subject to market risk, equity risk, foreign currency risk, liquidity risk, biotechnology, communication and technology sectors risk, debt securities risk, concentration risk, smaller and midsize companies risk, growth stocks risk, counterparty risk, Private Investments in Public Equity risk, private companies risk, special purpose acquisition companies risk and derivative instruments risk.
- Security lending transactions may involve the risk that the borrower may fail to return the securities lent out in a timely manner and the value of the collateral may fall below the value of the securities lent out, which may result in a substantial loss to the Fund.
- The Fund may at its discretion pay dividends out of the capital or out of gross income of the Fund while paying all or part of the Fund’s fees and expenses out of the capital of the Fund, which results in effectively paying dividends out of capital. Payment of dividends out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment. Any distributions involving payment of dividends out of the Fund’s capital or payment of dividends effectively out of the Fund’s capital (as the case may be) may result in an immediate reduction of the net asset value per share.
- Investors should not invest based on this marketing material alone. Offering documents should be read for further details, including the risk factors. Before you decide to invest, you should make sure the intermediary has explained to you that the Fund is suitable to you.
Franklin U.S. Opportunities Fund
- Franklin U.S. Opportunities Fund invests principally in equity securities of U.S. companies with strong growth potential across a wide range of sectors.
- The Fund is subject to market risk, equity risk, warrants risk, convertible securities risk, liquidity risk, concentration risk, growth stocks risk, smaller and midsize companies risk, foreign currency risk, RMB currency and conversion risk, class hedging risk, counterparty risk, Private Investments in Public Equity risk, private companies risk, special purpose acquisition companies risk and derivative instruments risk.
- Security lending may involve the risk that the borrower may fail to return the securities lent out in a timely manner and the value of the collateral may fall below the value of the securities lent out, which may result in a substantial loss to the Fund.
- The Fund may at its discretion pay dividends out of the capital or out of gross income of the Fund while paying all or part of the Fund’s fees and expenses out of the capital of the Fund, which results in effectively paying dividends out of capital. Payment of dividends out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment. Any distributions involving payment of dividends out of the Fund’s capital or payment of dividends effectively out of the Fund’s capital (as the case may be) may result in an immediate reduction of the net asset value per share.
- Investors should not invest based on this marketing material alone. Offering documents should be read for further details, including the risk factors. Before you decide to invest, you should make sure the intermediary has explained to you that the Fund is suitable to you.
From healthcare to finance, manufacturing to retail, artificial intelligence (AI) is transforming industries, sparking innovation and creating new opportunities. Now is the moment for investors to think forward, looking beyond traditional sectors to harness the potential of companies at the forefront of these profound changes. As technology becomes the growth engine of tomorrow, incorporating AI into your investment isn’t merely about staying relevant—it's about positioning for future opportunities.
Why invest in technology and innovation?
Investing in technology is more than just keeping pace—it's about seizing the future. As companies double down on AI and digital transformation, capital spending is surging, paving the way for groundbreaking advancements. This wave of innovation is creating entirely new opportunities that were unimaginable just a few years ago. By tapping into these trends, investors can position themselves to ride the next big wave of tech-driven growth and transformation, unlocking potential in a rapidly evolving world.
Source: Franklin Templeton, Bloomberg consensus estimates as of 9 October 2024.
E = Estimated
Amazon = Amazon Web Services only
There is no assurance that any projection, estimate or forecast will be realised.
Key drivers of change
Technology is evolving at an unprecedented pace, creating exciting investment opportunities as digital innovations transform industries, increase connectivity, and drive efficiency. From AI to cloud computing, these advancements are enhancing productivity and reshaping corporate profitability. By investing in technology, you can tap into these secular trends and capitalise on the ongoing digital transformation that continues to fuel growth.
1/8
1/8
For illustrative purposes only. Because market and economic conditions are subject to rapid change, the analysis and opinions provided may change without notice. Statements of fact are from sources considered reliable, but no representation or warranty is made as to their completeness or accuracy.
Featured funds
Ready to invest in tomorrow’s innovations today? We take a broad approach to technology, investing in companies that create, implement, and commercialise innovations across various sectors like AI and biotechnology, unlocking new potential for your portfolio.
Franklin Technology Fund
Focuses on capitalising on global technological innovation by investing in leading companies driving digital transformation. The Fund offers exposure to a wide range of tech sectors, from AI to cloud computing, with an emphasis on long-term growth opportunities in cutting-edge technology.
Benchmark Fund of the Year Awards 2022 – Information Technology Sector Equity (Outstanding Achiever)1
Franklin U.S. Opportunities Fund
Targeting high-potential U.S. companies, the Fund invests across multiple sectors, from healthcare to consumer goods, with a focus on growth-oriented businesses. Its diversified approach aims to balance risk while capturing market opportunities in established and emerging U.S. firms.
Franklin Biotechnology Discovery Fund
Specialising in biotechnology, the Fund invests in companies at the forefront of medical innovation, including genomics and gene therapy. It focuses on U.S.-based firms developing cutting-edge medical treatments, offering exposure to high-growth opportunities in the biotech sector.
Who manages these funds?
For 75+ years, the Franklin Equity Group has helped investors achieve their objectives through value and growth investing across global and local mandates. Backed by in-depth expertise and comprehensive research, the team employs a fundamental, bottom-up approach to identify companies with sustainable growth potential, delivering strong, long-term results.
Why Franklin Templeton?
Location: Our local presence in the heart of Silicon Valley provides early access to market developments, enabling swift decisions ahead of competitors.
Expertise: We recognise both industry leaders and emerging innovators overlooked by the market, capitalising on untapped growth potential
Access: As part of the Franklin Equity Group, our technology analysts leverage insights from across the group, strengthening decision-making
Dedication: Dedicated portfolio managers of our flagship equity funds have at least 17+ years of investing and industry experience2
Take your investment journey to the next level
Discuss with your financial advisors
Explore the list of distributors we work with.
